Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice

被引:87
作者
Tong, MH
Jiang, H
Liu, P
Lawson, JA
Brass, LF
Song, WC [1 ]
机构
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1038/nm1184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen sulfotransferase (EST, encoded by SULT1E1) catalyzes the sulfoconjugation and inactivation of estrogens. Despite decades of biochemical study and the recognition that high levels of estrogen sulfates circulate in the blood of pregnant and nonpregnant women, the physiological role of estrogen sulfation remains poorly understood. Here we show that ablation of the mouse Sult1e1 gene caused placental thrombosis and spontaneous fetal loss. This phenotype was associated with elevated free estrogen levels systemically and in the amniotic fluid, increased tissue factor expression in the placenta and heightened platelet sensitivity to agonist-induced activation ex vivo. Treatment of pregnant Sult1e1-null mice with either an anticoagulant or antiestrogen prevented the fetal loss phenotype. Our results thus identify Est as a critical estrogen modulator in the placenta and suggest a link between estrogen excess and thrombotic fetal loss. These findings may have implications for understanding and treating human pregnancy failure and intrauterine growth retardation.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 44 条
[21]   Fetal death in mice lacking 5 alpha-reductase type 1 caused by estrogen excess [J].
Mahendroo, MS ;
Cala, KM ;
Landrum, CP ;
Russell, DW .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (07) :917-927
[22]   The role of imprinted genes in fetal growth [J].
Miozzo, M ;
Simoni, G .
BIOLOGY OF THE NEONATE, 2002, 81 (04) :217-228
[23]  
MOORE SS, 1988, AUST J BIOL SCI, V41, P333
[24]   Nongenomic effects of 17β-estradiol in human platelets:: potentiation of thrombin-induced aggregation through estrogen receptor and Src kinase [J].
Moro, L ;
Reineri, S ;
Piranda, D ;
Pietrapiana, D ;
Lova, P ;
Bertoni, A ;
Graziani, A ;
Defilippi, P ;
Canobbio, I ;
Torti, M ;
Sinigaglia, F .
BLOOD, 2005, 105 (01) :115-121
[25]  
Nealen ML, 2001, CIRC RES, V88, P438
[26]   CLINICAL IMPLICATIONS OF PROSTAGLANDIN AND THROMBOXANE-A2 FORMATION .1. [J].
OATES, JA ;
FITZGERALD, GA ;
BRANCH, RA ;
JACKSON, EK ;
KNAPP, HR ;
ROBERTS, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (11) :689-698
[27]  
Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1
[28]  
Qian YM, 1998, J PHARMACOL EXP THER, V286, P555
[29]   Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation [J].
Qian, YM ;
Sun, XJ ;
Tong, MH ;
Li, XP ;
Richa, J ;
Song, WC .
ENDOCRINOLOGY, 2001, 142 (12) :5342-5350
[30]   Correlation between PAP-dependent steroid binding activity and substrate specificity of mouse and human estrogen sulfotransferases [J].
Qian, YM ;
Song, WC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 71 (3-4) :123-131